NICE guideline on
chronic heart failure
NYHA Score: Functional Classification of Heart Failure
- Class I Cardiac disease that does not limit normal physical activity.
(Normal physical exertion is not associated with undue fatigue, dyspnoea, or angina pain.) - Class II Patients with cardiac disease causing slight limitation of
physical activity.
(Comfortable at rest, ordinary physical activity results in fatigue, palpitation, SOB or angina) - Class III Patients with cardiac disease causing marked limitation of
their physical activity.
(Comfortable at rest, < ordinary physical activity causes fatigue, palpitation, SOB, or angina). - Class IV Patients with cardiac disease that prevents them carrying
out any physical activity without discomfort and onset of symptoms.
(Symptoms may be present at rest (angina, SOB). Symptoms increase with any
physical activity)
Investigation and management of congestive heart failure
-
- Perform echocardiography in patients with certain or probable heart failure to refine the diagnosis and plan treatment
-
- Measure brain natriuretic peptide (BNP) in patients with an uncertain diagnosis
-
- A normal BNP result is better than electrocardiography for diagnosing heart failure and rules out heart failure; if raised perform echocardiography
-
- Echocardiography can determine the underlying structure and function of heart failure
-
- It is crucial to distinguish heart failure with low ejection fraction from that with preserved ejection fraction because most high quality evidence on treatment is for patients with low ejection fraction
-
- While waiting for echocardiography (or if not available) give an angiotensin converting enzyme inhibitor and β blocker (where possible) and uptitrate to maximum doses
New York Heart Association classification of congestive heart failure and associated evidence based treatments
|
- *Any angiotensin converting enzyme inhibitor (ACE) inhibitor is recommended but not all have been evaluated in clinical trials.
-
Recommended
β blockers are carvedilol, bisoprolol, nebivolol, and metoprolol succinate
(not available in the UK). -
Avoid
giving an ACE inhibitor, angiotensin receptor blocker, and spironolactone
together because of the risk of hypotension and hyperkalaemia. -
Uncertainty
exists about angiotensin receptor blockers as a class because irbesartan is
not effective whereas candesartan is.
Investigation
and management of congestive heart failure 2010- ACEI
- Atrial fibrillation
- echocardiography
NICE guideline on
chronic heart failure
Diagnosis and management of adults with chronic heart failure: summary of
updated NICE guidance 2010-
Depression
in older adults (2011)β
blockers for heart failure with reduced ejection fraction (2011)
Left ventricular systolic dysfunction
Diagnosis in patients with suspected heart failure in primary care:

Major ECG abnormality:
|
Major CXR abnormality:
|
Detailed protocol:
- Introduction
- Diagnosis of heart failure
- Assessment of patients with left ventricular systolic dysfunction
- Treatment of patients with left ventricular
systolic dysfunction
- Non-pharmacological interventions
- Pharmacological interventions
- Management of acute left heart failure
35%; and if
their QRS duration is
150 ms or
120-149 ms with dyssynchrony measured on echocardiographyCardiac
resynchronisation therapy can improve symptoms and prognosis